<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="68630">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01671540</url>
  </required_header>
  <id_info>
    <org_study_id>PML_Kine_IPV</org_study_id>
    <secondary_id>artesis_G018</secondary_id>
    <nct_id>NCT01671540</nct_id>
  </id_info>
  <brief_title>Effects of IPV Assessed With Functional Imaging</brief_title>
  <acronym>IPV</acronym>
  <official_title>Evaluation of the Effects of Intrapulmonary Percussive Ventilation Using Functional Respiratory Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Antwerp</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Artesis University College, Antwerp</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>FluidDA nv</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Antwerp</source>
  <oversight_info>
    <authority>Belgium:</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study the invetigators seek an answer on the following hypothesis:

        -  What are the long term effects of an IPV treatment evaluated with classical outcome
           parameters? (FEV1, Raw)

        -  Is the possible effect noticeable on the novel technique and is this comparable with
           the classical outcome parameters?
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A Multicenter study conducted  in UZA and ZNA Middelheim. Tests are taken before and after
      one week IPV treatment. IPV is applied for 1 week during the physical therapy treatment of
      COPD patients admitted to the hospital for an excarebation.  The IPV treatment is an
      additional treatment upon the standard treatment of the patients.  The standard treatment
      consists out of existing drainage techniques to remove secretion out of the lungs by means
      of breathing control exercises.  Patients are randomized into either the experimental group
      or the control group. The control group receives a standard physical therapy treatment
      without additional IPV treatment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Lung function testing</measure>
    <time_frame>baseline and after one week</time_frame>
    <safety_issue>No</safety_issue>
    <description>(spirometric , bodybox en diffusion) Performed in the lung function laboratory according to ERS standards using Jaeger 5.1 device  VC, ESW, ESW/VC, PEF, MMEF 75/25, MEF 50, MEF 25, PIF, MIF 50, RV, TLC, FRC, resistance, spec resistance, TCO, VA, TCO/VA, MIP, MEP</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>functional respiratory imaging</measure>
    <time_frame>at baseline and after one week</time_frame>
    <safety_issue>No</safety_issue>
    <description>A 3D CT-scan  is take. Images are uploaded into a software program for post processing 3D images are made and images are post processed</description>
  </secondary_outcome>
  <other_outcome>
    <measure>questionnaires</measure>
    <time_frame>1 week</time_frame>
    <safety_issue>No</safety_issue>
    <description>St george Borg MRC</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>Intrapulmonary percussive ventilation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>IPV is applied for 1 week (once a day) during the physical therapy treatment of the patient</description>
  </arm_group>
  <arm_group>
    <arm_group_label>standard airwy claerance regime</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The standard treatment consists out of existing drainage techniques to remove secretion out of the lungs by means of breathing control exercises</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>intrapulmonary percussive ventilation</intervention_name>
    <arm_group_label>Intrapulmonary percussive ventilation</arm_group_label>
    <other_name>IMP 2 by Breas Sweden</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>standard treatment</intervention_name>
    <description>breathing control exercises</description>
    <arm_group_label>standard airwy claerance regime</arm_group_label>
    <other_name>Autogenic drainge</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients admitted in the hospital for a acute exacerbation

          -  Mild to severe COPD

        Exclusion Criteria:

          -  Ischemic / ventricular aritmic

          -  Tracheotomise

          -  Pneumothorax

          -  Facial deformity

          -  Recent nose, mouth or ear operations

          -  Recent gastric operations.

          -  Intubated

          -  Epilepsy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wilfried De Backer, Phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>UZA pneumology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kris Ides, Msc</last_name>
    <phone>036418267</phone>
    <email>kris.ides@artesis.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Antwerp</name>
      <address>
        <city>Edegem</city>
        <state>Antwerp</state>
        <zip>2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kris Ides, Msc</last_name>
      <phone>038213447</phone>
      <phone_ext>0032</phone_ext>
      <email>kris.ides@artesis.be</email>
    </contact>
    <investigator>
      <last_name>Wilfried De Backer, Phd</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 27, 2013</lastchanged_date>
  <firstreceived_date>August 20, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Antwerp</investigator_affiliation>
    <investigator_full_name>Wilfried De Backer</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>IPV</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Respiration Disorders</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
